FDA to speed up approval of generic drugs as Trump takes aim at drug costs
U.S. Food and Drug Administration Commissioner Marty Makary speaks during a news conference alongside U.S. Health and Human Services Secretary…
Pharmaceuticals
CVS Health (CVS) Third Quarter 2025 Earnings
Signage at a CVS pharmacy in Takoma Park, Maryland, USA, on Wednesday, July 9, 2025. To Drago | Bloomberg |…
Eli Lilly and Nvidia to build supercomputer and artificial intelligence factory for drug discovery
Eli Lilly and NVIDIA are partnering to build what they call the pharmaceutical industry's “most powerful” supercomputer and so-called artificial…
Novartis has potential for big M&A deals, CEO says
This photo taken on October 30, 2022 shows the logo of Swiss pharmaceutical company Novartis on a building in Basel.…
Novo Nordisk president and directors resign after board rift
The logos of Danish pharmaceutical company Novo Nordisk, maker of the successful diabetes and weight loss treatments Ozempic and Wegovy,…
Genentech Launches Direct-to-Consumer Program for Flu Pill Xofluza
A sign stands in front of a Genentech office on June 12, 2025 in south San Francisco, California. Justin Sullivan…
Trump announces efforts to expand access to IVF drugs
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC, on October…
Moderna lowers its sales forecast for 2025 by $1 billion
The Moderna Inc. headquarters in Cambridge, Massachusetts, USA, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | fake images…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
Medicare May Cover Eli Lilly's Zepbound for Sleep Apnea: Health Department Agency
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…